Catalyst
Slingshot members are tracking this event:
Nuvectra (NVTR) submits for premarket approval for Virtis, a neurostimulation technology, to TÜV SÜD America and the FDA in December 2016, January 2017.
- Source Link:
- http://seekingalpha.com/filing/3453426
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NVTR |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 31, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Neurostimulation, Virtis, Fda Review, Tuv Sud
